Tapping new tech helps marketers matchmake rare disease drugs for elusive patients
Treating rare diseases is challenging enough, so you can imagine how difficult it is to reach the right healthcare audiences with info about specialty …
Treating rare diseases is challenging enough, so you can imagine how difficult it is to reach the right healthcare audiences with info about specialty …
Audience Marketplace is the industry’s first and only cookieless-by-design healthcare data ecosystem, giving marketers the flexibility to immediately activate custom or ready-to-use audience segments …
DeepIntent’s Patient Modeled Audiences Solution Uses Industry’s Most Comprehensive Real-World Clinical Datasets to Precisely Reach Patient Populations, Including Those Facing Rare Diseases and Low …
Toward the end of every year, I call upon my leadership team to reflect on the year that has passed and the future of …
What trends can healthcare marketers expect in 2022? In this article for Endpoints News, CEO Chris Paquette discusses how pharma brands will be increasing …
2021 was an exciting year for DeepIntent. To name just a few achievements, we celebrated our fifth anniversary in April, grew our employee headcount …
NEW YORK, Dec. 13, 2021 — PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, …
DeepIntent Outcomes is our patented optimization engine that uses real-world clinical data and machine learning to optimize live campaigns by maximizing audience quality and/or …
Discover and reach MJH Life Sciences’ audience segments in the DeepIntent Audience Marketplace, the industry’s first and only cookieless-by-design healthcare data ecosystem. Immediately activate …
